Login / Signup

Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.

David NassimAbdulhadi H JfriIvan V LitvinovElena Netchiporouk
Published in: Journal of cutaneous medicine and surgery (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • electronic health record
  • big data
  • emergency department
  • adverse drug
  • machine learning
  • data analysis
  • artificial intelligence